Inclusion Criteria:  All patients that are treated with neutralizing monoclonal SARS-CoV-2 antibodies or with small-molecules for Covid-19 as standard of care. Patients have to be aged ≥ 18 y.  Exclusion Criteria:  No informed consent is provided by the patient or by his/her legal representative Patients not suitable to fulfil study procedures